These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 23280344

  • 1. Phenotype conversion from rheumatoid arthritis to systemic lupus erythematosus by introduction of Yaa mutation into FcγRIIB-deficient C57BL/6 mice.
    Kawano S, Lin Q, Amano H, Kaneko T, Nishikawa K, Tsurui H, Tada N, Nishimura H, Takai T, Shirai T, Takasaki Y, Hirose S.
    Eur J Immunol; 2013 Mar; 43(3):770-8. PubMed ID: 23280344
    [Abstract] [Full Text] [Related]

  • 2. Presumptive role of 129 strain-derived Sle16 locus in rheumatoid arthritis in a new mouse model with Fcγ receptor type IIb-deficient C57BL/6 genetic background.
    Sato-Hayashizaki A, Ohtsuji M, Lin Q, Hou R, Ohtsuji N, Nishikawa K, Tsurui H, Sudo K, Ono M, Izui S, Shirai T, Takai T, Nishimura H, Hirose S.
    Arthritis Rheum; 2011 Oct; 63(10):2930-8. PubMed ID: 21953083
    [Abstract] [Full Text] [Related]

  • 3. Anti-CD11b antibody treatment suppresses the osteoclast generation, inflammatory cell infiltration, and autoantibody production in arthritis-prone FcγRIIB-deficient mice.
    Ohtsuji M, Lin Q, Okazaki H, Takahashi K, Amano H, Yagita H, Nishimura H, Hirose S.
    Arthritis Res Ther; 2018 Feb 08; 20(1):25. PubMed ID: 29422084
    [Abstract] [Full Text] [Related]

  • 4. IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model.
    Ohtsuji M, Lin Q, Nishikawa K, Ohtsuji N, Okazaki H, Tsurui H, Amano H, Shirai T, Nishimoto N, Nishimura H, Hirose S.
    Mod Rheumatol; 2015 Mar 08; 25(2):270-7. PubMed ID: 25159156
    [Abstract] [Full Text] [Related]

  • 5. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K, Nakamura A, Sugahara A, Takai T.
    Eur J Immunol; 2003 Apr 08; 33(4):1020-9. PubMed ID: 12672068
    [Abstract] [Full Text] [Related]

  • 6. TNFα but not IL-17 is critical in the pathogenesis of rheumatoid arthritis spontaneously occurring in a unique FcγRIIB-deficient mouse model.
    Okazaki H, Lin Q, Nishikawa K, Ohtsuji N, Tsurui H, Ohtsuji M, Amano H, Tada N, Sudo K, Nishimura H, Shirai T, Hirose S.
    Mod Rheumatol; 2014 Nov 08; 24(6):931-8. PubMed ID: 24593165
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory IgG Fc receptor promoter region polymorphism is a key genetic element for murine systemic lupus erythematosus.
    Lin Q, Hou R, Sato A, Ohtsuji M, Ohtsuji N, Nishikawa K, Tsurui H, Amano H, Amano E, Sudo K, Nishimura H, Shirai T, Hirose S.
    J Autoimmun; 2010 Jun 08; 34(4):356-63. PubMed ID: 19758787
    [Abstract] [Full Text] [Related]

  • 8. The inhibiting Fc receptor for IgG, FcγRIIB, is a modifier of autoimmune susceptibility.
    Boross P, Arandhara VL, Martin-Ramirez J, Santiago-Raber ML, Carlucci F, Flierman R, van der Kaa J, Breukel C, Claassens JW, Camps M, Lubberts E, Salvatori D, Rastaldi MP, Ossendorp F, Daha MR, Cook HT, Izui S, Botto M, Verbeek JS.
    J Immunol; 2011 Aug 01; 187(3):1304-13. PubMed ID: 21724994
    [Abstract] [Full Text] [Related]

  • 9. The Yaa gene-mediated acceleration of murine lupus: Yaa- T cells from non-autoimmune mice collaborate with Yaa+ B cells to produce lupus autoantibodies in vivo.
    Fossati L, Sobel ES, Iwamoto M, Cohen PL, Eisenberg RA, Izui S.
    Eur J Immunol; 1995 Dec 01; 25(12):3412-7. PubMed ID: 8566031
    [Abstract] [Full Text] [Related]

  • 10. Contribution of NZB autoimmunity 2 to Y-linked autoimmune acceleration-induced monocytosis in association with murine systemic lupus.
    Kikuchi S, Santiago-Raber ML, Amano H, Amano E, Fossati-Jimack L, Moll T, Kotzin BL, Izui S.
    J Immunol; 2006 Mar 01; 176(5):3240-7. PubMed ID: 16493085
    [Abstract] [Full Text] [Related]

  • 11. Evidence for genes in addition to Tlr7 in the Yaa translocation linked with acceleration of systemic lupus erythematosus.
    Santiago-Raber ML, Kikuchi S, Borel P, Uematsu S, Akira S, Kotzin BL, Izui S.
    J Immunol; 2008 Jul 15; 181(2):1556-62. PubMed ID: 18606711
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Enforced Bcl-2 expression in B lymphocytes induces rheumatoid factor and anti-DNA production, but the Yaa mutation promotes only anti-DNA production.
    Kuroki A, Moll T, López-Hoyos M, Fossati-Jimack L, Ibnou-Zekri N, Kikuchi S, Merino J, Merino R, Izui S.
    Eur J Immunol; 2004 Apr 15; 34(4):1077-84. PubMed ID: 15048718
    [Abstract] [Full Text] [Related]

  • 14. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice.
    Merino R, Shibata T, De Kossodo S, Izui S.
    Eur J Immunol; 1989 Nov 15; 19(11):2131-7. PubMed ID: 2599002
    [Abstract] [Full Text] [Related]

  • 15. Selective expansion of a monocyte subset expressing the CD11c dendritic cell marker in the Yaa model of systemic lupus erythematosus.
    Amano H, Amano E, Santiago-Raber ML, Moll T, Martinez-Soria E, Fossati-Jimack L, Iwamoto M, Rozzo SJ, Kotzin BL, Izui S.
    Arthritis Rheum; 2005 Sep 15; 52(9):2790-8. PubMed ID: 16142734
    [Abstract] [Full Text] [Related]

  • 16. FcγRIIb on B Cells and Myeloid Cells Modulates B Cell Activation and Autoantibody Responses via Different but Synergistic Pathways in Lupus-Prone Yaa Mice.
    Lin Q, Ohtsuji M, Amano H, Tsurui H, Tada N, Sato R, Fukuyama H, Nishimura H, Verbeek JS, Hirose S.
    J Immunol; 2018 Dec 01; 201(11):3199-3210. PubMed ID: 30373853
    [Abstract] [Full Text] [Related]

  • 17. Unique primed status of microglia under the systemic autoimmune condition of lupus-prone mice.
    Nomura A, Noto D, Murayama G, Chiba A, Miyake S.
    Arthritis Res Ther; 2019 Dec 30; 21(1):303. PubMed ID: 31888754
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus.
    Richez C, Yasuda K, Bonegio RG, Watkins AA, Aprahamian T, Busto P, Richards RJ, Liu CL, Cheung R, Utz PJ, Marshak-Rothstein A, Rifkin IR.
    J Immunol; 2010 Jan 15; 184(2):796-806. PubMed ID: 20007534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.